Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early administration of edoxaban after acute ischemic stroke in patients with non-valvular atrial fibrillation
KCT0003380Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in ischemic stroke and Atrial fibrillation (AFib) comparing Early edoxaban initiation with Control (standard timing or standard of care) (2 arms). Started Jun 2018; status: completed.
02
Drugs
edoxaban
03
Conditions
ischemic strokeAtrial fibrillation (AFib)
Beyond the preview
Go deeper on KCT0003380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003380.